San Diego-based Debut Biotechnology, Inc. is expanding its agreement with L’Oréal SA to develop more than a dozen “vital, bio-identical” ingredients that will replace conventionally sourced ingredients currently used in L’Oréal’s global beauty and personal-care brands across skin, hair, color cosmetics and fragrances, the firm announced on 2 July.
L’Oreal Doubles Down On Biotech; LIFT Beauty Accelerator; EVER Skin Care Acquired; Cosmetics News
Through this exciting partnership and adoption of breakthrough technology, we are well-positioned to drive the creation of more sustainable and effective products that meet the demands of our consumers and fulfils our duty of care for the planet,” says L’Oréal Groupe’s Guive Balooch on the firm’s expanded partnership with Debut Biotechnology. More cosmetics news in brief.
More from Deals
• By
Kim Kardashian lifestyle company SKIMS buys back rights to SKKN by Kim from Coty, Inc., which had purchased a 20% interest in the brand in 2020 for $200m. Separately, NYX Professional Makeup partners with Warner Bros. to launch the “A Minecraft Movie” collection.
• By
L’Oréal USA has sold multi-cultural hair care brand Carol’s Daughter to an independent beauty entrepreneur with a ‘proven track record’ of acquiring and growing beauty brands, while it remains under the leadership of its founder and new President, Lisa Price.
• By
Egis is the beneficiary as Teva again trims its OTC portfolio with the sale of Hungarian skin-care brand Neogranormon.
• By
Italian personal care and beauty manufacturer Sodalis Group will acquire Alberto V05, Zest soap, Sure deodorants and other personal care brands in a transaction with current owner Tengram Capital Partners expected to close by the end of October. Recent years have seen high private equity activity in cosmetics and personal care.
More from Ingredients & Safety
• By
UK food toxicity committee says substantial exceedances of the Acceptable Daily Intake of turmeric - such as through excessive supplement use - represents a potential health risk to humans.
• By
The Expert Panel for Cosmetic Ingredient Safety issued a revised tentative amended report for p-phenylenediamine and related ingredients during its 171st meeting.
• By
FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.